Search - tctmd.com

Displaying 341 - 360 of 414

Sort: Relevancy | Date

News Daily News

Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI

May 11, 2015

News Daily News

Un Panel de la FDA Avala Cangrelor para ser Utilizado en PCI

April 29, 2015

News Daily News

FDA Panel Backs Cangrelor for Use in PCI

April 29, 2015

News Daily News

Vorapaxar可对先前患过心梗的糖尿病患者起到有效的二级预防作用

February 22, 2015

News Daily News

Vorapaxar Effective for Secondary Prevention in Diabetic Patients With Prior MI

February 22, 2015

News Daily News

SCAAR: Stent Thrombosis Risk After Primary PCI No Higher With Bivalirudin Than Other Antithrombotics

February 19, 2015

News Daily News

SCAAR: El Riesgo de Trombosis del Stent Post-PCI Primaria No es Mayor con Bivalirudina que con Otros Antitrombóticos

February 19, 2015

News Daily News

SCAAR：采用比伐卢定情况下的直接PCI后支架内血栓形成风险并非高于其他抗血栓形成疗法

February 19, 2015

Preloading P2Y12 Antagonists in NSTE-ACS and STEMI: Safe and Effective? What Regimens?

Presentation TCT 2014

Preloading P2Y12 Antagonists in NSTE-ACS and STEMI: Safe and Effective? What Regimens?

Presenter: Dominick J. Angiolillo

September 13, 2014

News Conference News ESC 2014

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

August 30, 2014

News Conference News EuroPCR 2014

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

Yael L. Maxwell

May 21, 2014

News Daily News

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

April 25, 2014

News Daily News

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

April 11, 2014

News Daily News

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

April 09, 2014

News Daily News

Un Panel de la FDA Rechaza el Cangrelor para las Indicaciones PCI y Terapia Puente

Yael L. Maxwell

February 13, 2014

News Daily News

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Yael L. Maxwell

February 13, 2014

Rapid-Acting Potent IV P2Y12 Inhibition: Evolution or Revolution?

Presentation TCT 2013

Rapid-Acting Potent IV P2Y12 Inhibition: Evolution or Revolution?

Presenter: Robert Harrington

October 27, 2013

News Daily News

Hypothermia Does Not Increase Stent Thrombosis Risk in Primary PCI Patients

October 16, 2013

News Daily News

控制良好的华法林不会降低三联疗法出血风险

August 30, 2013

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.